Explore more publications!
Nepal Healthcare Times
Got News to Share?

Nepal Healthcare Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nepal Healthcare Times.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 2, 2025

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio
December 2, 2025

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio

Indeterminate GlobeNewswire
Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer
December 2, 2025

Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer

Indeterminate GlobeNewswire
Amneal to Participate in Upcoming Investor Conferences
December 2, 2025

Amneal to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
December 2, 2025

Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies

Indeterminate GlobeNewswire
Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
December 2, 2025

Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
AnewHealth Names Ken Burdick Chairman of Board of Directors
December 2, 2025

AnewHealth Names Ken Burdick Chairman of Board of Directors

Indeterminate GlobeNewswire
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.
December 2, 2025

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

Indeterminate GlobeNewswire
Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership
December 2, 2025

Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership

Indeterminate GlobeNewswire
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol
December 2, 2025

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

Indeterminate GlobeNewswire
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ Technology for Oligomer-Selective Antibodies and Recruitment Strategies for Phase 2 ALTITUDE-AD Clinical Trial at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
December 2, 2025

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ Technology for Oligomer-Selective Antibodies and Recruitment Strategies for Phase 2 ALTITUDE-AD Clinical Trial at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Indeterminate GlobeNewswire
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
December 2, 2025

TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen

Indeterminate GlobeNewswire
Alkeus Pharmaceuticals Appoints Renowned Retina Specialist and Biotech Executive Carlos Quezada-Ruiz, M.D., F.A.S.R.S., as Chief Medical Officer
December 2, 2025

Alkeus Pharmaceuticals Appoints Renowned Retina Specialist and Biotech Executive Carlos Quezada-Ruiz, M.D., F.A.S.R.S., as Chief Medical Officer

Indeterminate GlobeNewswire
Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
December 2, 2025

Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Indeterminate GlobeNewswire
Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium
December 2, 2025

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium

Indeterminate GlobeNewswire
Electra Therapeutics Presents SURPASS Pivotal ELA026 Study Design and Highlights the Critical Unmet Need in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) at the ASH 2025 Annual Meeting
December 2, 2025

Electra Therapeutics Presents SURPASS Pivotal ELA026 Study Design and Highlights the Critical Unmet Need in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) at the ASH 2025 Annual Meeting

Indeterminate GlobeNewswire
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4
December 2, 2025

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4

Indeterminate GlobeNewswire
Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
December 2, 2025

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain

Indeterminate GlobeNewswire
Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology
December 2, 2025

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

Indeterminate GlobeNewswire
Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
December 2, 2025

Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

Indeterminate GlobeNewswire
HealthLynked Expands Board of Directors With Addition of Two Leading Insurance Executives: Chris G. Pulos of Marsh McLennan and Jason Bishara of NSI Insurance
December 2, 2025

HealthLynked Expands Board of Directors With Addition of Two Leading Insurance Executives: Chris G. Pulos of Marsh McLennan and Jason Bishara of NSI Insurance

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions